NKTX - Nkarta, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Nkarta, Inc.
IPO Date: July 10, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $162.59M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.54 | 4.44%
Avg Daily Range (30 D): $0.11 | 4.07%
Avg Daily Range (90 D): $0.13 | 4.76%
Institutional Daily Volume
Avg Daily Volume: .78M
Avg Daily Volume (30 D): .52M
Avg Daily Volume (90 D): .56M
Trade Size
Avg Trade Size (Sh.): 127
Avg Trade Size (Sh.) (30 D): 112
Avg Trade Size (Sh.) (90 D): 106
Institutional Trades
Total Institutional Trades: 675
Avg Institutional Trade: $1.7M
Avg Institutional Trade (30 D): $.76M
Avg Institutional Trade (90 D): $1.15M
Avg Institutional Trade Volume: .11M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.71M
Avg Closing Trade (30 D): $.76M
Avg Closing Trade (90 D): $1.15M
Avg Closing Volume: 113.17K
 
News
Sep 8, 2026 @ 11:00 AM
Nkarta to Present Initial Autoimmune Clinical Data...
Source: Na
Jun 26, 2026 @ 12:45 PM
Nkarta to Participate in H.C. Wainwright 4th Annua...
Source: Na
Apr 6, 2026 @ 5:00 PM
Idiopathic Membranous Nephropathy Market is Predic...
Source: Delveinsight
Feb 27, 2026 @ 1:00 PM
Nkarta to Participate in March Investor Conference...
Source: Na
Apr 1, 2025 @ 12:01 PM
Nkarta to Participate in an April Investor Confere...
Source: N/A
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.58 $-.54 $-.37
Diluted EPS $-1.58 $-.54 $-.37
Revenue $M $M $M
Gross Profit
Net Income / Loss $-117.32M $-40.37M $-27.83M
Operating Income / Loss $-132.25M $-43.13M $-30.88M
Cost of Revenue
Net Cash Flow $-28.46M $-2.4M $-12.28M
PE Ratio